Blaze at Danish drugmaker Novo Nordisk is the third in a little over a month
A fire has broken out at an office building belonging to Danish pharmaceutical company Novo Nordisk, the third in a little over a month to hit the drugmaker
Your support helps us to tell the story
As your White House correspondent, I ask the tough questions and seek the answers that matter.
Your support enables me to be in the room, pressing for transparency and accountability. Without your contributions, we wouldn't have the resources to challenge those in power.
Your donation makes it possible for us to keep doing this important work, keeping you informed every step of the way to the November election
Andrew Feinberg
White House Correspondent
A fire broke out Tuesday at an office building belonging to Danish pharmaceutical company Novo Nordisk, the third in a little more over a month to hit the drugmaker.
There were no reports of injuries and police said the blaze was under control.
Flames were seen at the top of a three-story building in Bagsvaerd in suburban Copenhagen. The cause of the fire was being investigated.
Danish media said neighbors heard a large explosion in connection with the fire. Firefighters said on the social media platform X that the blasts “presumably” were caused by gas canisters on the roof that exploded.
Lars Otto Andersen-Lange, a spokesperson for Novo Nordisk, told the BT tabloid that the fire was in an office building and not at the headquarters.
“There is nothing to suggest that there was anything criminal behind the fire today or the previous ones,” Andersen-Lange said.
Last month, two fires were reported at a company facility under construction in Kalundborg, about 90 kilometers (55 miles) west of Copenhagen, and at an administration building in Bagsvaerd. No one was injured.
Novo Nordisk has several facilities in western Denmark and produces the popular weight-loss drug Wegovy.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.